Valuation: Stereotaxis, Inc.

Market Cap 139M 120M 113M 103M 193M 13.32B 196M 1.32B 518M 6.67B 523M 512M 22.19B P/E 2026 *
-6.73x
P/E 2027 * -9.27x
Enterprise Value 139M 120M 113M 103M 193M 13.32B 196M 1.32B 518M 6.67B 523M 512M 22.19B EV / Sales 2026 *
3.94x
EV / Sales 2027 * 2.92x
Free-Float
84.79%
Yield 2026 *
-
Yield 2027 * -
1 day+0.72%
1 week-3.47%
Current month+10.32%
1 month-10.32%
3 months-24.86%
6 months-33.17%
Current year-39.57%
1 week 1.3
Extreme 1.3
1.5
1 month 1.24
Extreme 1.24
1.63
Current year 1.24
Extreme 1.24
2.86
1 year 1.24
Extreme 1.24
3.59
3 years 1.24
Extreme 1.24
3.59
5 years 1.24
Extreme 1.24
7.32
10 years 0.47
Extreme 0.47
10.3
Manager TitleAgeSince
Chief Executive Officer - 02/02/2017
Director of Finance/CFO 57 30/09/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 31/01/2005
Chairman - 02/02/2017
Director/Board Member 71 28/09/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Free

Director

43,103 0.0441%
01/07/26 Free

Director

43,103 0.0441%
01/07/26
DAFNA Capital Management LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%-3.47%-49.08%-8.55% 139M
-0.47%-2.36%+19.73%+9.25% 216B
+0.09%-3.22%-3.93%-19.85% 142B
-1.06%-0.78%-18.73%+34.56% 138B
-0.77%+1.92%-50.15%+0.96% 74.53B
-0.86%-1.33%+16.04%+18.20% 52.34B
+0.58%-1.14%-17.13%-14.00% 50.28B
-0.05%-0.18%+24.54%+22.84% 41.93B
-1.07%-0.98%+39.85%+49.27% 40.06B
-1.79%-0.78%-1.40%+5.82% 32.69B
Average -0.04%-0.82%-4.03%+9.85% 78.88B
Weighted average by Cap. +0.12%-1.16%-0.07%+9.36%

Financials

2026 *2027 *
Net sales 35.33M 30.5M 28.62M 26.06M 49.01M 3.38B 49.69M 335M 131M 1.69B 133M 130M 5.63B 47.67M 41.15M 38.61M 35.16M 66.12M 4.56B 67.03M 453M 177M 2.28B 179M 175M 7.6B
Net income -20.47M -17.67M -16.58M -15.1M -28.39M -1.96B -28.78M -194M -76.15M -980M -76.84M -75.18M -3.26B -15.27M -13.18M -12.36M -11.26M -21.18M -1.46B -21.47M -145M -56.8M -731M -57.32M -56.08M -2.43B
Net Debt - -
Logo Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
131
Date Price Change Volume
17/08/26 US$1.390 +0.72% 706,569
14/08/26 US$1.380 0.00% 733,107
13/08/26 US$1.380 -1.43% 451,033
12/08/26 US$1.400 -4.11% 1,373,699
11/08/26 US$1.460 +1.39% 793,357
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.390USD
Average target price
3.333USD
Spread / Average Target
+139.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STXS Stock